BMET - Biomet $38.19 -0.31 (+1.38)

Biomet has been mostly immune to the NASDAQ collapse this week. Biomet is a major innovator of equipment used for orthopedic surgery and treatment. There is currently a huge demand for the company's products. Biomet is expected to post solid profits of $0.29 a share on December 13th. If the Company meets estimates, it will increase profits over the same year-ago quarter by $0.04. Biomet does trade at a healthy P/E of 55.34, but with so few options out there, investors continue to flock to the stock. Biomet bucked yesterday's ugly market and plowed ahead to a new all time high of $40.25. Today, we saw the stock pull back a bit. The profit taking can be attributed to the fact that the stock is now overbought according to the Relative Strength Index (RSI). Nevertheless, the stock is still in a decided up trend and new highs appear to be in the stock's future. The MACD is solid and reflects the current positive trend. Money Flow is strong, but this indicator has leveled recently. Slow and steady wins the race. We do not expect Biomet to take off, but a steady stair-stepping ascent is a definite possibility. We are maintaining our stop at $33.00, which is $0.75 below the 50-DMA. We have placed a trailing stop suggestion in our In Play section. If we are not stopped out, we will exit this position either right before the earnings announcement or right after a split announcement.

Picked on October 31st @ $36.19 Change since picked +2.00

CEFT - Concord EFS $43.00 -0.50 (+1.19)

Concord EFS, a provider of authorization and processing services for ATM cards and credit cards, has been testing support as the market awaits the outcome of the Presidential election. On Thursday, shares of CEFT traded down to an intra-day low of $41.88 on average volume. However, the stock closed at $43 after a bounce off of the 10-dma of $42.00. CEFT has spent the past seven sessions consolidating in the $40-$45 range, and it may continue to mark time there until the election results are finalized. In the meantime, CEFT has support at the 10-dma, with stronger support at the 20-dma at $39.88. Resistance has moved down to the November 8 intra-day high of $43.88, followed by the all-time high of $46.13. Traders could consider new plays on a bounce off of $42 or a move above $43.88 on volume greater than 1 million shares by midday. We are keeping our stop-loss at $37 to minimize losses.

Picked on October 31st @ $41.31 Change since picked +1.69